An AI-driven tool that tailors antidepressant treatment to individual patients was shown to improve outcomes for people with depression, compared to standard treatment, in a major international trial.

A web-based tool that incorporates patient preference in antidepressant selection was associated with a significant decrease ...

A new mom shares how the recently approved two-week postpartum depression drug was a game-changer to combat a notably common condition during a tender phase of life.

Transcranial magnetic stimulation (TMS, or "rTMS" for "repetitive TMS") received an indication for treating major depressive disorder in 2008. Since then, research and clinical experience with TMS has ...

A clinical trial is underway to test a drug-free stimulation therapy to see if it can relieve symptoms of postpartum depression.

When prescription depression drugs fall short in efficacy, there’s an off-label way to help them work better: add-on doses of thyroid hormone. Clinicians have long known about this approach and some ...

AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) highlighted progress across its clinical pipeline and reaffirmed its financial outlook during its 2026 Virtual Investor Day, outlining plans to advance its ...

TMS is a well-established therapy for treatment-resistant depression. Large clinical studies show that it significantly reduces symptoms in 60 to 70% of patients, and 25 to 35% achieve remission. Most ...

While research is new and not legal in every state, psychedelic treatments show promising results for treatment-resistant depression, PTSD, and other mental health conditions. Share on Pinterest ...

Credit: Getty Images Our helpful fact sheet informs patients about the risks, benefits, and considerations associated with postpartum depression medication. Our easy-to-read fact sheets provide ...